GE HEALTHCARE FDA Approval NDA 010220

NDA 010220

GE HEALTHCARE

FDA Drug Application

Application #010220

Application Sponsors

NDA 010220GE HEALTHCARE

Marketing Status

Discontinued002
Discontinued003

Application Products

002INJECTABLE;INJECTION60%;30%0HYPAQUE-M,90%DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
003INJECTABLE;INJECTION50%;25%0HYPAQUE-M,75%DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1955-11-09STANDARD
LABELING; LabelingSUPPL17AP1974-01-29STANDARD
S; SupplementSUPPL21AP1976-01-21STANDARD
LABELING; LabelingSUPPL22AP1976-01-21STANDARD
LABELING; LabelingSUPPL23AP1976-01-26STANDARD
LABELING; LabelingSUPPL24AP1976-04-08STANDARD
LABELING; LabelingSUPPL25AP1978-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1978-02-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1978-02-01STANDARD
LABELING; LabelingSUPPL28AP1978-03-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1979-02-17STANDARD
LABELING; LabelingSUPPL30AP1984-08-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1983-02-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL32AP1983-11-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1988-05-23STANDARD
LABELING; LabelingSUPPL34AP1984-09-13STANDARD
LABELING; LabelingSUPPL35AP1985-06-26STANDARD
LABELING; LabelingSUPPL36AP1985-07-24STANDARD
LABELING; LabelingSUPPL37AP1986-06-25STANDARD
LABELING; LabelingSUPPL38AP1986-06-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL39AP1990-02-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL40AP1989-04-11STANDARD
LABELING; LabelingSUPPL41AP1989-05-19STANDARD
LABELING; LabelingSUPPL42AP1989-06-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL43AP1991-04-24STANDARD
LABELING; LabelingSUPPL44AP1991-10-03STANDARD
LABELING; LabelingSUPPL45AP1990-09-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL46AP1994-03-25STANDARD

Submissions Property Types

ORIG1Null0
SUPPL17Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL35Null0
SUPPL36Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL40Null0
SUPPL41Null0
SUPPL42Null0
SUPPL43Null0
SUPPL44Null0
SUPPL45Null0
SUPPL46Null0

CDER Filings

GE HEALTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 10220
            [companyName] => GE HEALTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYPAQUE-M,75%","activeIngredients":"DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","strength":"50%;25%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"HYPAQUE-M,90%","activeIngredients":"DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","strength":"60%;30%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYPAQUE-M,75%","submission":"DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","actionType":"50%;25%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"HYPAQUE-M,90%","submission":"DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM","actionType":"60%;30%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.